-
Focusing on the Patient: Individualised Treatment for Wet AMD
Friday 7 September 10:00 – 11:00 | Room: Red Hall 1 & 2
Moderators: F. Holz GERMANY
- Introduction
- M. Larsen DENMARK
The Evolution of Wet AMD Management: Past, Present and Future
- F. Holz GERMANY
Informing Therapy and Dosing Choices in Wet AMD Through Emerging Data
- T. Wong SINGAPORE
Building on our Understanding of the Safety of Anti-VEGF Therapy in Wet AMD
- Panel Discussion and Audience Questions
REGISTER INTERESTSponsored by: 
-
The Argus ® II Retinal Prosthesis, the New Treatment Pathway for Retinitis
Pigmentosa and Future Perspectives
Friday 7 September 10:00 – 11:00 | Room: White Hall 1
Moderators:
R. Greenberg, M.D., Ph.D., President of Second Sight Medical Products,
G. Cosendai Ph.D., VP Europe of Second Sight Medical Products
- S. Rizzo ITALY
What can be Done Today for Retinitis Pigmentosa, The New Treatment Pathway
- J. A. Sahel FRANCE
What are the Future Prospects for Retinal Prostheses
REGISTER INTERESTSponsored by: 
-
Management of Retinal Disease, Today and in the Future
Friday 7 September 13:00 – 14:00 | Room: Red Hall 1 & 2
Moderators: F. Bandello ITALY, G. Coscas FRANCE
13.00 - Welcome
-
13:03 - W. Drexler AUSTRIA
Diagnosis of Retinal Disease, Today and in the Future
- 13:15 - J. Ambati USA
Inflammation in Retinal Disease - New Insights
- 13:27 - F. Bandello ITALY
Management of RVO – Efficacy and Safety
- 13:37 - A. Loewenstein ISRAEL
RVO in Clinical Practice
- 13:48 - A. Tufail UK
Management of RVO – What Does it Mean for the Health Care System and our Patients
- 13.58
Conclusion & Close
REGISTER INTERESTSponsored by: 
-
Stellaris PC: Fundamentals + Futures. Complex Cases and Insights into Innovation
Friday 7 September 13:00 – 14:00 | Room: Blue Hall 1
Moderator: Y. Le Mer FRANCE
13.00 - Welcome & Introduction- 13.05 - F. Fayyad JORDAN
Versatility in Approaches to Managing Complex Cases
- 13.20 - R. Sheard UK
Highlights and Contrast: Insights in Illumination
- 13.35 - B. Parolini ITALY
Innovation in Challenging Cases
- 13.50 - All Panel Q&A
-
- REGISTER INTERESTSponsored by:
-
Innovative Improvements for Retinal Imaging Diagnosis and Laser Treatment
Friday 7 September 13:00 – 14:00 | Room: Yellow Hall 3
Moderator: E. Midena ITALY
- D. Wechsler AUSTRALIA
Clinical Application of New NIDEK OCT
- E. Midena ITALY
Clinical Application of New NIDEK OCT Retina and Choroid
- S. Prasad UK
Multicolor Scan Laser Photocoagulator Provides Efficiencies in the Clinic
- REGISTER INTERESTSponsored by:
-
The Evolution of RVO Management with Ranibizumab: Applying the Evidence to the Clinic
Friday 7 September 18.15 | Room: Red Hall 1 & 2
Moderator: I. Pearce UK
-
Introduction
- I. Pearce UK
Perspectives on the Management of RVO: The Rationale for Anti VEGF Therapies
- F. Boscia ITALY
Advances in the Management of RVO: Outcomes from Clinical Trials
- D. Brown USA
Lessons from the Clinic: Current Challenges in RVO Management and the Role of Ranibizumab
- Panel Discussion and Audience Questions
REGISTER INTERESTSponsored by: -
Latest Trends in Surgical and Medical Retina
Saturday 8 September 10:00 – 11:00 |
Room: Red Hall 1 & 2
Moderator: A. Augustin GERMANY
-
-
- C. Claes BELGIUM
Challenging Surgical Cases with MIVS
- S. Rizzo ITALY
New Ultra High-Speed Vitrectomy Probe Technology
- A. Tufail UK
Role of Enzymatic Vitreolysis to Resolve Vitreomacular Traction
- A. Augustin GERMANY
Pharmacologic Management of Macular Holes
- Panel discussion
REGISTER INTERESTSponsored by:
-
-
EVA by DORC, a New Dimension in Vitreoretinal Surgery
Saturday 8 September 10:00 – 11:00 |
Room: Blue Hall 1
- C. Eckardt GERMANY
My First Experience with EVA
- F. Pavlidis GERMANY
New Technologies in 27G Surgery
- P. Stalmans BELGIUM, J. van Calster BELGIUM
Live Surgery EVA Hands-on Techniques
- A. Mohr GERMANY
Posterior Dyes
- G. Pertile ITALY
High Myopic Surgery
REGISTER INTERESTSponsored by: 
-
-
Long-Term Outcomes with Ranibizumab in DME: Implications for Individualised Patient Management
- Saturday 8 September 13:00 – 14:00 |
Room: Red Hall 1 & 2
- Moderator: F.Bandello ITALY
- Introduction
- U. Schmidt-Erfurth GERMANY
Long-Term Outcomes with Ranibizumab: Results from the RESTORE Study
- S. Bressler USA
Ranibizumab in Combination with Laser: Long-Term Results from DRCR.net Protocol I
- F. Bandello ITALY
A DME Casebook: Application of Ranibizumab in Individualized Care
- Panel Discussion and Audience Questions
REGISTER INTERESTSponsored by: -
-
Exploring Novel Options for Wet AMD Therapy
- Saturday 8 September 13:00 – 14:00 | Room: Blue Hall 1
- Moderators: P. Lanzetta ITALY, G. Staurenghi ITALY
- 13.00 - Moderators
Introduction
-
13.05 - G. Staurenghi ITALY
The Burden of wAMD and Impact of anti-VEGF Therapies
- 13.20 - J. F Korobelnik FRANCE
Clinical Trial Results
- 13.40 - P. Stanga UK
Balance of the Evidence in wAMD Management
- 13.55 - Chairman
Summary
- 14.00
Close
REGISTER INTERESTSponsored by: 
-
-
New Dimensions in Ophthalmic Imaging
- Saturday 8 September 13:00 – 14:00 | Room: White Hall 1
- Moderator: S.Schulz GERMANY (Heidelberg Engineering GmbH)
-
F. Holz GERMANY
SPECTRALIS MultiColor and More- A. Scheuerle GERMANY
A New Paradigm in Glaucoma Diagnosis
- S. Wolf SWITZERLAND
Novel Techniques in Retinal Imaging
REGISTER INTERESTSponsored by: 
-
-
Oraya Therapy – A Significant Advance in the Treatment of Wet AMD
- Saturday 8 September 18.15 | Room: White Hall 1
Moderator: T. Jackson UK
-
- 18.00 - Room Opens
18.15 - Refreshments
-
18:30
-
F. Bandello ITALY
Welcome and Introduction
-
18:35
- D. Moshfeghi USA
Oraya Therapy Overview
-
18:45
- U. Chakravarthy UK
Ionising Radiation and nvAMD: Radiobiological Considerations
- 18.55 - T. Jackson UK
INTREPID Data and Its Significance
- 19.05 - U. Chakravarthy UK
Angiographic and Tomographic Outcomes in the INTREPID Study
- 19.15 - A. Luff UK
Implementation of the Oraya Therapy in the United Kingdom
- 19.25 - J. Taylor USA
Concluding Remarks
- 19.30 - Refreshments
- 19.45 - Adjourn
REGISTER INTEREST
- Sponsored by:
-
-
Topcon Retina Symposium
- Saturday 8 September 18.15 - 19.15 | Room: Blue Hall 1
- Moderator: P. Stanga UK
- P. Stanga UK
Sub Threshold Treatment of the Retina with PASCAL
- J. M. Ruíz Moreno SPAIN
Choroidal Imaging Topcon DRI OCT-1
- F. Balta ROMANIA
OMS-800 OFFISS Visualisation for 25 G High Speed Vitrectomy
- U. Vossmerbäumer GERMANY
Glaucoma Analysis and OCT Screening
- P. Stanga UK
Imaging the Vitreous and the Vitreoretinal Interface – Topcon DRI OCT-1
REGISTER INTEREST
Sponsored by: 
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org
